In a research note issued Wednesday, JMP Securities analyst Liisa Bayko reiterated an Underperform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) with a $10 …
JMP Securities analyst Liisa Bayko was out with a research note on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), after the biotech company released uneventful second-quarter results …
Biotechnology company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) fell about 10% in trading on Wednesday, May 20 following the company’s announcement that it licensed its …
